Treatment of periodontitis, before chemotherapy, reduces inflammation markers! Oral health 21. 07. 2022 We know that (a) Chemotherapy can cause bleeding of the gums, with gingival and periodontium inflammation and infection. (b) Ιn cancer patients, gingivitis and periodontal infection have been associated with fever and generalized inflammation during chemotherapy, especially during periods when white blood- cell counts fall, with a negative impact on treatment success. How is periodontitis related to cancer? A recent study showed that people with breast cancer have worse periodontal health after chemotherapy. Additionally, gingivitis and periodontitis promote complications in the gums, periodontium and jaws, when a patient receives bone medications, biological, targeted therapies and immunotherapy. The treatment of gingivitis and periodontitis prior to chemotherapy In the present study, the gingival inflammation profile was examined in patients with breast cancer and periodontitis, before and after conservative treatment of periodontitis (without surgical intervention). Periodontitis was treated before chemotherapy. The patients, after the periodontal treatment, entered a maintenance program, with checks on the health of their gums and maintenance of good oral hygiene. Results Periodontal treatment prior to chemotherapy and subsequent maintenance of gingival health during chemotherapy reduced markers of inflammation in cancer patients that were associated with periodontitis. Also, conservative periodontal treatment helped reduce the inflammation profile to reduce periodontitis flare-ups. Conclusions Conservative periodontal treatment can increase the resistance of periodontal tissues to acute changes during chemotherapy. This beneficial effect of healing of the gums and maintaining good oral health is important and is expected to reduce fever and generalized inflammation during chemotherapy. Tags: periodontitis , chemotherapy
The 3-Step Safety System for Medication-Related Osteonecrosis of the Jaw (MRONJ) Events, Seminars, & Publications 07. 04. 2026 How to Confidently Treat Patients Taking Antiresorptive MedicationsIn our first two webinars, more than 600 dentists discovered a system that changes the way they manage high-risk patients.Their react...[Read more]
Advanced protocols for the management of high-risk patients Events, Seminars, & Publications 10. 02. 2026 Οστεονέκρωση Γνάθων (MRONJ): Από τη Θεωρία στην Πράξη - 3ο Webinar ΕξειδίκευσηςWhat Happened in the Previous Webinars?On January 16, 180 dentists attended the first webinar.On February 6, 174 dentists...[Read more]
Conference of the Hellenic Society of Head and Neck Cancer Events, Seminars, & Publications 18. 11. 2025 The Conference of the Hellenic Society of Head and Neck Cancer took place on 7–8 November 2025 at LAED in Athens with outstanding success, high participation, and a rich scientific program.The high q...[Read more]